-->

Tech Seeker (TS)

Axys Pharmaceuticals Inc (AKA:Sequana Therapeutics Inc~Akkadix Corporation)
Profile last edited on: 6/19/2013

Small-molecule drug discovery
TS Type
Small Corporation
Status
Acquired
Year Founded
1989
Last Involved Year
1996

Key People / Management

Location Information

180 Kimball Way
South San Francisco, CA 94080
   (858) 452-6550
   www.axyspharm.com

Public Profile

Formerly doing business as Arris Pharmceuticals and as Akkadix Corporation. Axys Pharmaecuticals was formed when Arris joined with Sequana Therapeutics in January 98. Functioning as a edicinal and structural chemistry company Axys was then itself acquired by Applera's Celera Genomics. The original firm was a genomics company focused on discovery, design, and development of therapeutic small molecules that used industrial-scale gene finding technologies, advanced biology and bioinformatics to uncover the genetic cause of common human diseases. With gene discovery programs in asthma, diabetes, obesity, osteoporosis, schizophrenia, manic depression, prostate cancer and other important disease areas, Sequana is well-positioned to find disease-causing genes, determine their biological function, and translate gene discoveries into novel diagnostic and therapeutic products.

Extent of SBIR involvement

User Avatar

Synopsis: Techseeker Business Condition

Headquartered
USA
Employment
N/A
Revenue
N/A
Public/Private
Publicly Traded
Stock Info
NASDAQ : AXPH
Received SBIR $$
Yes

SBIR firms in the news

There are no news available.